These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 25173801)
21. Hyperbilirubinemia and rapid fatal hepatic failure in severe combined immunodeficiency caused by adenosine deaminase deficiency (ADA-SCID). Kühl JS; Schwarz K; Münch A; Schmugge M; Pekrun A; Meisel C; Wahn V; Ebell W; von Bernuth H Klin Padiatr; 2011 Mar; 223(2):85-9. PubMed ID: 21271505 [TBL] [Abstract][Full Text] [Related]
22. ADA Deficiency: Evaluation of the Clinical and Laboratory Features and the Outcome. Cagdas D; Gur Cetinkaya P; Karaatmaca B; Esenboga S; Tan C; Yılmaz T; Gümüş E; Barış S; Kuşkonmaz B; Ozgur TT; Bali P; Santisteban I; Orhan D; Yüce A; Cetinkaya D; Boztug K; Hershfield M; Sanal O; Tezcan İ J Clin Immunol; 2018 May; 38(4):484-493. PubMed ID: 29744787 [TBL] [Abstract][Full Text] [Related]
28. FOXN1 in organ development and human diseases. Palamaro L; Romano R; Fusco A; Giardino G; Gallo V; Pignata C Int Rev Immunol; 2014 Mar; 33(2):83-93. PubMed ID: 24432845 [TBL] [Abstract][Full Text] [Related]
29. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510 [TBL] [Abstract][Full Text] [Related]
30. Sp1 is an important transcriptional regulation factor for forkhead box N1 in pig. Zhang DJ; Wang L; Li ZQ; Fu B; Yang GW J Genet; 2018 Mar; 97(1):319-322. PubMed ID: 29666351 [TBL] [Abstract][Full Text] [Related]
31. Severe combined immunodeficiency (SCID)-associated dyschromia with subsequent repigmentation: a report of two patients. Heath CR; Burk CJ; Lawley LP; Mancini AJ; Connelly EA Pediatr Dermatol; 2009; 26(2):162-8. PubMed ID: 19419463 [TBL] [Abstract][Full Text] [Related]
32. Transient recovery of endogenous immune function following haploidentical peripheral stem cell transplantation in a patient with severe combined immunodeficiency without evidence of engraftment. Levy J; Amar A; Brautbar C; Slavin S; Kapelushnik J Acta Paediatr; 2000 Feb; 89(2):248-50. PubMed ID: 10709900 [No Abstract] [Full Text] [Related]
33. [Severe combined immunodeficiency: From its discovery to the perspective]. Kanegane H; Imai K; Morio T Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):145-154. PubMed ID: 28747600 [TBL] [Abstract][Full Text] [Related]
34. Low T cell receptor excision circles (TRECs) in a case of ZAP 70 deficient severe combined immunodeficiency (SCID) with a novel mutation from India. Aluri J; Italia K; Gupta M; Dalvi A; Bavdekar A; Madkaikar M Blood Cells Mol Dis; 2017 Jun; 65():95-96. PubMed ID: 27839984 [No Abstract] [Full Text] [Related]
35. Unique heterozygous presentation in an infant with DNA ligase IV syndrome. Brunet BA; Dave N Ann Allergy Asthma Immunol; 2017 Oct; 119(4):379-380. PubMed ID: 28866308 [No Abstract] [Full Text] [Related]
36. Long term outcomes of severe combined immunodeficiency: therapy implications. Heimall J; Cowan MJ Expert Rev Clin Immunol; 2017 Nov; 13(11):1029-1040. PubMed ID: 28918671 [TBL] [Abstract][Full Text] [Related]
37. A novel mutation in the JH4 domain of JAK3 causing severe combined immunodeficiency complicated by vertebral osteomyelitis. Qamar F; Junejo S; Qureshi S; Seleman M; Bainter W; Massaad M; Chou J; Geha RS Clin Immunol; 2017 Oct; 183():198-200. PubMed ID: 28917720 [TBL] [Abstract][Full Text] [Related]